£2.33m
+10%vs Mar 2024Active04934116Private limited companyCambridge
IGENNUS LIMITED
Significant control: Javad Nazemi (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Igennus Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Igennus Limited sell?
Registered activity: Other research and experimental development on natural sciences and engineering (SIC 72190). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
IGENNUS LIMITED is an active private limited company (company number 04934116) incorporated on 16 October 2003, registered in Cambridge. Its registered activity is other research and experimental development on natural sciences and engineering (SIC 72190). Latest small accounts cover the period ending 31 March 2025, showing net assets of £2.33m and cash of £227k, with 20 employees on average. Net assets rose 10% on the prior period (£2.11m).
Peer position · net assets
By net assets it sits in the top quarter of 193 comparable companies in Cambridge (median £6,914, upper quartile £134k).
02
Ownership and control
- Dr Javad Nazemi
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 16 October 200323 yrs ago
- Next accounts due
- 31 December 2026in 68 days
- Confirmation statement due
- 30 October 2026in 6 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- SIC 86900
- Other human health activities
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£227k
−61%vs Mar 2024Not reported
20
No changevs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £2.33m | £227k | £1.35m | £2.83m | — | — | 20 |
| 31 March 2024 | £2.11m | £582k | £1.54m | £1.66m | — | — | 20 |
Current ratio1.97Current assets ÷ creditors within one year
Cash per employee£11kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £2,334,680 at 31 March 2025
- Net assets up 10% or more on the prior period+10.4% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 1.97
- Cash at bank of £50,000 or moreCash £227,275
- Incorporated five or more years agoIncorporated 16 October 2003
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 68 days
- Confirmation statement duein 6 days
- Accounts period endNet assets £2.33m · small accounts
- Accounts period endNet assets £2.11m · small accounts
- Incorporated
08
Similar companies in Cambridge
- OWLSTONE MEDICAL LIMITEDCambridge · inc. Nov 2003
- BLUEWOLF COMMUNICATIONS LIMITEDWhittlesford · inc. Nov 2003
- ALTERIX LIMITEDCambridge · inc. Aug 2003
- GRANTA BIOTECHNOLOGY LIMITEDCambridge · inc. Aug 2003
- MOLECULAR SYNTHETICS LIMITEDCambridge · inc. Dec 2003
- INOTEC AMD LIMITEDCambridge · inc. Dec 2003
All companies incorporated on 16 October 2003 · in Oct 2003.
09
Reminders for IGENNUS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.